Cutaneous Chronic Graft-Versus-Host Disease: Clinical Manifestations, Diagnosis, Management, and Supportive Care
- PMID: 39370234
- PMCID: PMC12396616
- DOI: 10.1016/j.jtct.2024.05.020
Cutaneous Chronic Graft-Versus-Host Disease: Clinical Manifestations, Diagnosis, Management, and Supportive Care
Abstract
Cutaneous chronic graft-versus-host disease (cGVHD) is associated with morbidity, mortality, and impaired quality of life after hematopoietic stem cell transplantation. The clinical features of cutaneous cGVHD are heterogeneous but can be broadly classified into nonsclerotic or sclerotic presentations. This review provides an overview of clinical presentation, diagnosis and differential diagnosis, grading, and treatment of cutaneous cGVHD. Particular attention is given to cutaneous cGVHD in skin of color, which can have unique features and is generally underrepresented in the literature leading to delays in diagnosis. Finally, an overview of long-term skin care for patients with cutaneous cGVHD is provided in order to support patients from a dermatologic perspective as they recover from cGVHD. Multidisciplinary care with frequent communication between transplant specialists and dermatologists is critical to effectively managing cutaneous cGVHD.
Keywords: Cutaneous graft versus host disease.
Copyright © 2024 The American Society for Transplantation and Cellular Therapy. All rights reserved.
Conflict of interest statement
Conflict of Interest Statement CRS: Editorial: VisualDX. HKC: Research: Opna. Consulting: Incyte, Sanofi, Abbvie, Actinium. BHK: Research: Biogen, Merck, InflaRx, BMS, Dermatology Foundation, National Psoriasis Foundation. Consulting: Novartis, Novocure, ADC Therapeutics, Elsevier.
Figures


















References
-
- Stem Cell Trialists’ Collaborative Group. Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of hematologic malignancies: an individual patient data meta-analysis of nine randomized trials. J Clin Oncol: Off J Am Soc Clin Oncol. 2005;23(22):5074–5087. 10.1200/JCO.2005.09.020. - DOI - PMC - PubMed
-
- Kitko CL, Pidala J, Schoemans HM, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IIa. The 2020 clinical implementation and early diagnosis working group report. Transplant Cell Ther. 2021;27(7):545–557. 10.1016/j.jtct.2021.03.033. - DOI - PMC - PubMed
-
- Flowers MED, Parker PM, Johnston LJ, et al. Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial. Blood. 2002;100(2):415–419. 10.1182/blood-2002-01-0011. - DOI - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical